These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20221880)

  • 1. The contribution of high density lipoprotein apolipoproteins and derivatives to serum paraoxonase-1 activity and function.
    James RW; Deakin SP
    Adv Exp Med Biol; 2010; 660():173-81. PubMed ID: 20221880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of HDL mimetic peptide 4F on PON1.
    Vakili L; Hama S; Kim JB; Tien D; Safarpoor S; Ly N; Vakili G; Hough G; Navab M
    Adv Exp Med Biol; 2010; 660():167-72. PubMed ID: 20221879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution spectrum of paraoxonase activity in HDL fractions.
    Bergmeier C; Siekmeier R; Gross W
    Clin Chem; 2004 Dec; 50(12):2309-15. PubMed ID: 15459089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ApoE induces serum paraoxonase PON1 activity and stability similar to ApoA-I.
    Gaidukov L; Viji RI; Yacobson S; Rosenblat M; Aviram M; Tawfik DS
    Biochemistry; 2010 Jan; 49(3):532-8. PubMed ID: 20025294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Very low density lipoproteins provide a vector for secretion of paraoxonase-1 from cells.
    Deakin S; Moren X; James RW
    Atherosclerosis; 2005 Mar; 179(1):17-25. PubMed ID: 15721005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraoxonase-1 and oxidized lipoprotein lipids. The Cardiovascular Risk in Young Finns Study.
    Kresanov P; Vasankari T; Ahotupa M; Kaikkonen J; Hutri-Kähönen N; Juonala M; Kähönen M; Lehtimäki T; Viikari J; Raitakari OT
    Atherosclerosis; 2015 Aug; 241(2):502-6. PubMed ID: 26091975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High affinity, stability, and lactonase activity of serum paraoxonase PON1 anchored on HDL with ApoA-I.
    Gaidukov L; Tawfik DS
    Biochemistry; 2005 Sep; 44(35):11843-54. PubMed ID: 16128586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coincubation of PON1, APO A1, and LCAT increases the time HDL is able to prevent LDL oxidation.
    Hine D; Mackness B; Mackness M
    IUBMB Life; 2012 Feb; 64(2):157-61. PubMed ID: 22184096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidized-phospholipids in reconstituted high density lipoprotein particles affect structure and function of recombinant paraoxonase 1.
    Kar S; Patel MA; Tripathy RK; Bajaj P; Pande AH
    Biochim Biophys Acta; 2013 Dec; 1831(12):1714-20. PubMed ID: 23973798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of caloric restriction and gender on rat serum paraoxonase 1 activity.
    Thomàs-Moyà E; Gianotti M; Lladó I; Proenza AM
    J Nutr Biochem; 2006 Mar; 17(3):197-203. PubMed ID: 16214326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of high-density lipoproteins for paraoxonase-1 secretion, stability, and activity.
    James RW; Deakin SP
    Free Radic Biol Med; 2004 Dec; 37(12):1986-94. PubMed ID: 15544917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between selected oxidative stress markers and lipid risk factors for cardiovascular disease in middle-aged adults and its possible clinical relevance.
    Viktorinova A; Svitekova K; Stecova A; Krizko M
    Clin Biochem; 2016 Aug; 49(12):868-72. PubMed ID: 27240017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bovine paraoxonase 1 activities in serum and distribution in lipoproteins.
    Miyamoto T; Takahashi Y; Oohashi T; Sato K; Oikawa S
    J Vet Med Sci; 2005 Mar; 67(3):243-8. PubMed ID: 15805725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of paraoxonase 1 is associated with HDL remodeling ex vivo.
    Gugliucci A
    Clin Chim Acta; 2014 Feb; 429():38-45. PubMed ID: 24280342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender related differences in paraoxonase 1 response to high-fat diet-induced oxidative stress.
    Thomàs-Moyà E; Gómez-Pérez Y; Fiol M; Gianotti M; Lladó I; Proenza AM
    Obesity (Silver Spring); 2008 Oct; 16(10):2232-8. PubMed ID: 18719679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of paraoxonase 1 polymorphisms on the response of lipids and lipoprotein-associated enzymes to treatment with fluvastatin.
    Christidis DS; Liberopoulos EN; Kakafika AI; Miltiadous GA; Liamis GL; Kakaidi B; Tselepis AD; Cariolou MA; Elisaf MS
    Arch Med Res; 2007 May; 38(4):403-10. PubMed ID: 17416287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exclusive association of paraoxonase 1 with high-density lipoprotein particles in apolipoprotein A-I deficiency.
    Noto H; Hashimoto Y; Satoh H; Hara M; Iso-o N; Togo M; Kimura S; Tsukamoto K
    Biochem Biophys Res Commun; 2001 Nov; 289(2):395-401. PubMed ID: 11716486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
    Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzymatically active paraoxonase-1 is located at the external membrane of producing cells and released by a high affinity, saturable, desorption mechanism.
    Deakin S; Leviev I; Gomaraschi M; Calabresi L; Franceschini G; James RW
    J Biol Chem; 2002 Feb; 277(6):4301-8. PubMed ID: 11726658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic inflammation, intestine, and paraoxonase-1.
    Vakili L; Navab KD; Shabihkhani M; Pourtabatabaei N; Vazirian S; Barseghian Z; Seyedali S; Hough G
    Adv Exp Med Biol; 2014; 824():83-8. PubMed ID: 25038995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.